You just read:

QRxPharma Announces Strategic Partnership with Actavis; Agreement for U.S. Sales of MoxDuo® IR to Address the $2.5 Billion Acute Pain Market in 2012

News provided by

QRxPharma

21 Dec, 2011, 01:07 GMT